Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study

MLA

Eun Bong Lee, et al. “Comparative Risk of Osteoporotic Fracture among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Cohort Study.” Osteoporosis International, vol. 31, June 2020, pp. 2131–39. EBSCOhost, https://doi.org/10.1007/s00198-020-05488-9.

APA

Eun Bong Lee, Yun Jong Lee, Yeong Wook Song, Eun Hye Park, You Jung Ha, Eun Ha Kang, Y. H. Dong, & Anna Shin. (2020). Comparative risk of osteoporotic fracture among patients with rheumatoid arthritis receiving TNF inhibitors versus other biologics: a cohort study. Osteoporosis International, 31, 2131–2139. https://doi.org/10.1007/s00198-020-05488-9

Chicago

Eun Bong Lee, Yun Jong Lee, Yeong Wook Song, Eun Hye Park, You Jung Ha, Eun Ha Kang, Y. H. Dong, and Anna Shin. 2020. “Comparative Risk of Osteoporotic Fracture among Patients with Rheumatoid Arthritis Receiving TNF Inhibitors versus Other Biologics: A Cohort Study.” Osteoporosis International 31 (June): 2131–39. doi:10.1007/s00198-020-05488-9.